JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266291

Human GNG5 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GNG5 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2 and 7 bp deletion in exon 2.

View Alternative Names

FLJ92393, GBG5_HUMAN, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5, OTTHUMP00000011474, OTTHUMP00000011565

3 Images
Sanger Sequencing - Human GNG5 knockout HEK-293T cell line (AB266291)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNG5 knockout HEK-293T cell line (AB266291)

Allele-2 : 2 bp deletion in exon 2.

Sanger Sequencing - Human GNG5 knockout HEK-293T cell line (AB266291)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNG5 knockout HEK-293T cell line (AB266291)

Allele-3 : 1 bp insertion in exon 2.

Sanger Sequencing - Human GNG5 knockout HEK-293T cell line (AB266291)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNG5 knockout HEK-293T cell line (AB266291)

Allele-1 : 7 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2 and 7 bp deletion in exon 2

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266291-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266291 Human GNG5 knockout HEK-293T cell line", "number":"AB266291-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266291-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266291 Human GNG5 knockout HEK-293T cell line", "number":"AB266291-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GNG5
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GNG5 also known as Guanine Nucleotide-Binding Protein G(I)/G(S)/G(O) Subunit Gamma-5 plays a role in the function of G protein-coupled receptors (GPCRs). It is a small protein subunit with a known mass of about 8 kDa. This protein is expressed in many tissues making it widely available for participation in various signaling pathways. The main function of GNG5 revolves around its association with the other G protein subunits in signal transduction where it is important in transmitting extracellular signals processed by receptors.
Biological function summary

GNG5 functions as part of the larger G protein complex. It interacts with G alpha and G beta subunits to form the complete heterotrimeric G protein essential for GPCR signal transduction. By facilitating GDP-GTP exchange in the G alpha component GNG5 helps in activating downstream signaling cascades that influence physiological functions. Its involvement in cellular communication highlights its importance in biological processes like sensory perception and hormone responses.

Pathways

GNG5 participates importantly in the G protein signaling pathway and the GPCR downstream pathway. During signal transduction GNG5 interacts with the G beta subunit to maintain the functional G protein state. This protein also has a relationship with other G proteins such as GNAI1 (Guanine Nucleotide Binding Protein Alpha Inhibiting Activity Polypeptide 1) reflecting its coordination in complex signaling pathways. These pathways are integral to key cellular responses and adaptability to external stimuli.

GNG5 has a connection to conditions like cancer and metabolic disorders. Aberrant expression or dysfunction of this protein could lead to disruptions in normal signaling contributing to oncogenic pathways. GNG5's interactions with other G proteins such as GNAS (Guanine Nucleotide Binding Protein Alpha Stimulating) highlight its involvement in disease-linked molecular mechanisms. Its role in these disorders makes it a potential target for therapeutic research.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com